During a scheduled markup hearing of three key patent bills today, Senators Thom Tillis (R-NC) and Chris Coons (D-DE) ...

This belief is bolstered by the FDA's own initial decision not to grant any exclusivities to TYVASO DPI when ... we have now ...

Powered by member dues and donations, the FSF can only continue to be the cornerstone of a more just digital society with your support. Build a better world with us by matching the average donation of ...

On October 18, 2024, the United States Patent and Trademark Office’s (USPTO) final rules governing Motion to Amend practice ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third ...

Psychology graduate Leah Vanono enrolled in the program to further develop her internationally patent-pending protective ...

Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL Study; Post-Market ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...

Tom Hale, CEO of the Oura Ring company says he doesn't think Apple will release a smart ring as "it's hard to do this product ...

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today provided a corporate update and reported financial ...